181 related articles for article (PubMed ID: 25691613)
1. Multimodality approaches for the curative treatment of esophageal cancer.
Jang R; Darling G; Wong RK
J Natl Compr Canc Netw; 2015 Feb; 13(2):229-38. PubMed ID: 25691613
[TBL] [Abstract][Full Text] [Related]
2. Perioperative chemo(radio)therapy versus primary surgery for resectable adenocarcinoma of the stomach, gastroesophageal junction, and lower esophagus.
Ronellenfitsch U; Schwarzbach M; Hofheinz R; Kienle P; Kieser M; Slanger TE; Jensen K;
Cochrane Database Syst Rev; 2013 May; (5):CD008107. PubMed ID: 23728671
[TBL] [Abstract][Full Text] [Related]
3. Preoperative chemotherapy for resectable thoracic esophageal cancer.
Malthaner R; Fenlon D
Cochrane Database Syst Rev; 2001; (1):CD001556. PubMed ID: 11279723
[TBL] [Abstract][Full Text] [Related]
4. A rationale multidisciplinary approach for treatment of esophageal and gastroesophageal junction cancer: Accurate review of management and perspectives.
Chiappa A; Andreoni B; Dionigi R; Spaggiari L; Foschi D; Polvani G; Orecchia R; Fazio N; Pravettoni G; Cossu ML; Galetta D; Venturino M; Ferrari C; Macone L; Crosta C; Bonanni B; Biffi R
Crit Rev Oncol Hematol; 2018 Dec; 132():161-168. PubMed ID: 30447922
[TBL] [Abstract][Full Text] [Related]
5. Radiotherapy versus surgery within multimodality protocols for esophageal cancer--a meta-analysis of the randomized trials.
Pöttgen C; Stuschke M
Cancer Treat Rev; 2012 Oct; 38(6):599-604. PubMed ID: 22116018
[TBL] [Abstract][Full Text] [Related]
6. Multimodality therapy of local regional esophageal cancer.
Kelsen DP
Semin Oncol; 2005 Dec; 32(6 Suppl 9):S6-10. PubMed ID: 16399422
[TBL] [Abstract][Full Text] [Related]
7. [Combined-modality therapy for locoregional esophageal cancer].
Kim SB
Korean J Gastroenterol; 2004 Oct; 44(4):179-85. PubMed ID: 15505428
[TBL] [Abstract][Full Text] [Related]
8. Clinical aspects of multimodality therapy for resectable locoregional esophageal cancer.
Shinoda M; Hatooka S; Mori S; Mitsudomi T
Ann Thorac Cardiovasc Surg; 2006 Aug; 12(4):234-41. PubMed ID: 16977291
[TBL] [Abstract][Full Text] [Related]
9. Adjuvant (postoperative) therapy for esophageal cancer.
Ku GY; Ilson DH
Thorac Surg Clin; 2013 Nov; 23(4):525-33. PubMed ID: 24199702
[TBL] [Abstract][Full Text] [Related]
10. Current trends in multimodality treatment of esophageal and gastroesophageal junction cancer - Review article.
Klevebro F; Ekman S; Nilsson M
Surg Oncol; 2017 Sep; 26(3):290-295. PubMed ID: 28807249
[TBL] [Abstract][Full Text] [Related]
11. Trimodality therapy and definitive chemoradiotherapy for esophageal cancer: a single-center experience and review of the literature.
Hategan M; Cook N; Prewett S; Hindmarsh A; Qian W; Gilligan D
Dis Esophagus; 2015 Oct; 28(7):612-8. PubMed ID: 24863560
[TBL] [Abstract][Full Text] [Related]
12. Gefitinib in definitive management of esophageal or gastroesophageal junction cancer: a retrospective analysis of two clinical trials.
Sohal DP; Rice TW; Rybicki LA; Rodriguez CP; Videtic GM; Saxton JP; Murthy SC; Mason DP; Phillips BE; Tubbs RR; Plesec T; McNamara MJ; Ives DI; Bodmann JW; Adelstein DJ
Dis Esophagus; 2015; 28(6):547-51. PubMed ID: 24849395
[TBL] [Abstract][Full Text] [Related]
13. [Oesophageal cancer: current status of multimodality therapy].
Vallböhmer D; Schröder W; Brabender J; Hölscher AH
Zentralbl Chir; 2011 Aug; 136(4):312-6. PubMed ID: 21863509
[TBL] [Abstract][Full Text] [Related]
14. The Society of Thoracic Surgeons practice guidelines on the role of multimodality treatment for cancer of the esophagus and gastroesophageal junction.
Little AG; Lerut AE; Harpole DH; Hofstetter WL; Mitchell JD; Altorki NK; Krasna MJ
Ann Thorac Surg; 2014 Nov; 98(5):1880-5. PubMed ID: 25262396
[No Abstract] [Full Text] [Related]
15. Multimodality therapy for the curative treatment of cancer of the esophagus and gastroesophageal junction.
Ku GY; Ilson DH
Expert Rev Anticancer Ther; 2008 Dec; 8(12):1953-64. PubMed ID: 19046115
[TBL] [Abstract][Full Text] [Related]
16. Controversies in the multimodality management of locally advanced esophageal cancer: evidence-based review of surgery alone and combined-modality therapy.
Iyer R; Wilkinson N; Demmy T; Javle M
Ann Surg Oncol; 2004 Jul; 11(7):665-73. PubMed ID: 15197012
[TBL] [Abstract][Full Text] [Related]
17. Cancer of the gastroesophageal junction: combined modality therapy.
Ilson DH
Surg Oncol Clin N Am; 2006 Oct; 15(4):803-24. PubMed ID: 17030275
[TBL] [Abstract][Full Text] [Related]
18. Pre- and postoperative treatment modalities for esophageal squamous cell carcinoma.
Thallinger CM; Kiesewetter B; Raderer M; Hejna M
Anticancer Res; 2012 Nov; 32(11):4609-27. PubMed ID: 23155224
[TBL] [Abstract][Full Text] [Related]
19. EMR as salvage treatment for patients with locoregional failure of definitive chemoradiotherapy for esophageal cancer.
Hattori S; Muto M; Ohtsu A; Boku N; Manabe T; Doi T; Ishikura S; Yoshida S
Gastrointest Endosc; 2003 Jul; 58(1):65-70. PubMed ID: 12838223
[TBL] [Abstract][Full Text] [Related]
20. Radiotherapy in the multimodality management of esophageal cancer.
Encheva E; Kolev N; Tonev A; Ignatov V; Shterev S; Petrov D; Zlatarov A; Koleva I; Chaushev B; Kirilova T; Ivanov K
Khirurgiia (Sofiia); 2014; (3):12-9. PubMed ID: 25799618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]